-
[1]
雷周云, 张玲霞, 蒋性凡, 欧阳琼莲, 陆江春, 李安信, 1991: The Clinical Investigation of the Combined Treatment of Interferon and Chinese drugs on Patients with Chronic Active Hepatitis B, Virologica Sinica, 6, 107-.
-
[2]
熊开钧, 王心禾, 金慰鄂, 黄华芳, 姚梦林, 曾令兰, 韩才英, 范红梅, 吴章琦, 孙继山, 1986: EFFECT OF SMALL DOSAGE OF INTERFERON ON VIRAL MARKERS OF CHRONIC HEPATITIS B, Virologica Sinica, 1, 9-.
-
[3]
熊开钧, 黄华芳, 金慰鄂, 姚梦林, 曾令兰, 贺永文, 何生松, 吴章琦, 1986: THE INFLUENCE OF SMALL DOSAGES OF INTERFERON ON VIRUSES ON DIFFERENT STAGES OF CHRONIC HEPATITIS B, Virologica Sinica, 1, 24-.
-
[4]
黄华芳, 熊开钧, 何生松, 李瑗, 王萍, 蔡淑清, 曾令兰, 王心禾, 1991: The Observation on the Antiviral Effect of Ribavirin and Combining with Interferon in Patients with Chronic Hepatitis B, Virologica Sinica, 6, 201-.
-
[5]
黄华芳, 熊开钧, 王心禾, 金慰鄂, 曾令兰, 吴章琦, 1987: THE FOLLOWED-UP OBSERVATION OF ANTIVIRAL TREATMENT WITH SMALL DOSE INTERFERON IN CHRONIC HEPATITIS B, Virologica Sinica, 2, 34-.
-
[6]
黄华芳, 熊开钧, 王心禾, 曾令兰, 李嫒, 贺永文, 杨泽川, 凌美霞, 范家珍, 吴章琦, 1989: The Contrast Observation of Antiviral Effect of Interferon with Two Different Dosages in Chronic Hepatitis B, Virologica Sinica, 4, 383-.
-
[7]
赵文彬, 黄浦昌, 王行钵, 吴桃林, 周克捷, 张秀惠, 张元英, 林克泳, 1990: Efficacy of Treating Chronic Hepatitis B with HB Vaccine and Small Doses of Interferon and Thymosin, Virologica Sinica, 5, 379-.
-
[8]
黄华芳, 熊开钧, 曾令兰, 何生松, 杨泽川, 1994: Observation on the Antiviral Effect of HBIG .Acyclovir and Interferon Combining Treatment in Chronic Hepatitis B, Virologica Sinica, 9, 304-.
-
[9]
黄华芳, 熊开钧, 王心禾, 曾令兰, 刘彼息, 曾凡珍, 吴章琦, 1990: Followed-up Observation on Antiviral Effect of Combined Treatment of Small Dosage of Interferon and Thymosin in Patients with Chronic Hepatitis B, Virologica Sinica, 5, 69-.
-
[10]
Huang Cao, Wandi Zhu, Qingxia Han, Rongjuan Pei, Xinwen Chen, 2014: Construction of a chimeric hepatitis C virus replicon based on a strain isolated from a chronic hepatitis C patient, Virologica Sinica, 29, 61-70. doi: 10.1007/s12250-014-3408-z
-
[11]
Minghui Li, Lu Zhang, Yao Lu, Qiqi Chen, Huihui Lu, Fangfang Sun, Zhan Zeng, Gang Wan, Linqing Zhao, Yao Xie, 2021: Early Serum HBsAg Kinetics as Predictor of HBsAg Loss in Patients with HBeAg-Negative Chronic Hepatitis B after Treatment with Pegylated Interferonα-2a, Virologica Sinica, 36, 311-320. doi: 10.1007/s12250-020-00290-7
-
[12]
Minghui Li, Fangfang Sun, Xiaoyue Bi, Yanjie Lin, Liu Yang, Yao Lu, Lu Zhang, Gang Wan, Wei Yi, Linqing Zhao, Yao Xie, 2022: Consolidation treatment needed for sustained HBsAg-negative response induced by interferon-alpha in HBeAg positive chronic hepatitis B patients, Virologica Sinica, 37, 390-397. doi: 10.1016/j.virs.2022.03.001
-
[13]
Qing-Qing Ma, Hong-Jiang Wang, Jian Li, Meng-Qi Li, Tian-Shu Cao, Xiao-Yan Wu, Hong-Ying Qiu, Hui Zhao, Cheng-Feng Qin, 2022: The infectivity and pathogenicity of hepatitis A virus live-attenuated vaccine strain H2 in type I interferon receptor-deficient mice, Virologica Sinica, 37, 740-745. doi: 10.1016/j.virs.2022.07.009
-
[14]
Yan-zi CHANG, Yan-chang LEI, Wen WU, Shan-shan CHEN, Han-ju HUANG, Dong-liang YANG, Meng-ji LU, 2007: Effect of Hepatitis C Virus Core Protein on Interferon-Induced Antiviral Genes Expression and Its Mechanisms, Virologica Sinica, 22, 374-379.
-
[15]
熊开钧, 黄华芳, 王心禾, 金慰鄂, 曾令兰, 杨泽川, 凌美霞, 张雪珍, 吴章琦, 1987: THE TREATMENT EFFECT OF HEPATITIS B WITH INTERFERON AND ACYCLOVIR, Virologica Sinica, 2, 17-.
-
[16]
程志, 孙国萍, 王淑君, 王春生, 1999: Prelim inary Study on Fermentation Broth of Yeast Strain SH2 Enhancing Biological Activity of Interferon Alpha and Its Active Principle, Virologica Sinica, 14, 273-279.
-
[17]
Zengguo Cao, Chenchen Liu, Cheng Peng, Yong Ran, Yulin Yao, Gengfu Xiao, Entao Li, Zixi Chen, Xia Chuai, Sandra Chiu, 2023: Ebola virus VP35 perturbs type I interferon signaling to facilitate viral replication, Virologica Sinica, 38, 922-930. doi: 10.1016/j.virs.2023.10.004
-
[18]
Wei Yang, Chong-Yang Tang, Dong-Ying Fan, Yi-Song Wang, Pei-Gang Wang, Jing An, Guo-Ming Luan, 2024: Mice with type I interferon signaling deficiency are prone to epilepsy upon HSV-1 infection, Virologica Sinica, 39, 251-263. doi: 10.1016/j.virs.2024.01.002
-
[19]
Song Hu, Fahu Yuan, Lingyan Feng, Fang Zheng, Feili Gong, Hanju Huang, Binlian Sun, 2018: KIR2DL2/C1 is a Risk Factor for Chronic Infection and Associated with Non-response to PEG-IFN and RBV Combination Therapy in Hepatitis C Virus Genotype 1b Patients in China, Virologica Sinica, 33, 369-372. doi: 10.1007/s12250-018-0042-1
-
[20]
余晖, 未久仙, 熊开钧, 吴章琦, 1986: A PRELIMINARY REVIEW OF TREATING HEPATITIS B BY USING SMALL DOSAGE INTERFERON, Virologica Sinica, 1, 55-.